Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohortUlf M Geisen, Dennis K Berner, Florian Tran, Melike Sümbül, Lena Vullriede, Maria Ciripoi, Hayley M Reid, Annika Schaffarzyk, Ann C Longardt, Jeanette Franzenburg, Paula Hoff, Jan H Schirmer, Rainald Zeuner, Anette Friedrichs, Andrea SteinbachSee the full list of authors
24 March 2021
SARS-CoV-2 vaccination responses in untreated, conventionally treated and anticytokine-treated patients with immune-mediated inflammatory diseasesDavid Simon, Koray Tascilar, Filippo Fagni, Gerhard Krönke, Arnd Kleyer, Christine Meder, Raja Atreya, Moritz Leppkes, Andreas E Kremer, Andreas Ramming, Milena L Pachowsky, Florian Schuch, Monika Ronneberger, Stefan Kleinert, Axel J HueberSee the full list of authors
6 May 2021
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritisIrina Gessl, Mihaela Popescu, Victoria Schimpl, Gabriela Supp, Thomas Deimel, Martina Durechova, Miriam Hucke, Michaela Loiskandl, Paul Studenic, Michael Zauner, Josef S Smolen, Daniel Aletaha, Peter Mandl
12 January 2021
Impact of the COVID-19 pandemic on the disease course of patients with inflammatory rheumatic diseases: results from the Swiss Clinical Quality Management cohortAdrian Ciurea, Eleftherios Papagiannoulis, Kristina Bürki, Isabell von Loga, Raphael Micheroli, Burkhard Möller, Andrea Rubbert-Roth, Michael Andor, René Bräm, Angela Müller, Diana Dan, Diego Kyburz, Oliver Distler, Almut Scherer, Axel Finckh
22 September 2020
Mining social media data to investigate patient perceptions regarding DMARD pharmacotherapy for rheumatoid arthritisChanakya Sharma, Samuel Whittle, Pari Delir Haghighi, Frada Burstein, Roee Sa'adon, Helen Isobel Keen
3 September 2020
Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC)Riitta Tuompo, Tinja Lääveri, Timo Hannu, Sari H Pakkanen, Juha Kirveskari, Marjatta Leirisalo-Repo, Anu Kantele
16 March 2020
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and SwedenTine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling, Lene Dreyer
11 March 2020
Rare genetic variants in interleukin-37 link this anti-inflammatory cytokine to the pathogenesis and treatment of goutViola Klück, Rosanne C van Deuren, Giulio Cavalli, Amara Shaukat, Peer Arts, Maartje C Cleophas, Tania O Crișan, Anne-Kathrin Tausche, Philip Riches, Nicola Dalbeth, Lisa K Stamp, Jennie Harré Hindmarsh, Tim L Th A Jansen, Matthijs Janssen, Marloes SteehouwerSee the full list of authors
29 February 2020
Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessationTawnie J Braaten, Julie R Brahmer, Patrick M Forde, Dung Le, Evan J Lipson, Jarushka Naidoo, Megan Schollenberger, Lei Zheng, Clifton O Bingham 3rd, Ami A Shah, Laura C Cappelli
20 September 2019
Shotgun metagenomics reveals an enrichment of potentially cross-reactive bacterial epitopes in ankylosing spondylitis patients, as well as the effects of TNFi therapy upon microbiome compositionJian Yin, Peter Richard Sternes, Mingbang Wang, Jing Song, Mark Morrison, Ting Li, Ling Zhou, Xin Wu, Fusheng He, Jian Zhu, Matthew A Brown, Huji Xu
29 October 2019
